This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SAMUEL J. N. SUGAR, M.D.; LAWRENCE J. THOMAS, M.D.; TEODORA M. EUGENIO, M.D.

AMA Arch Intern Med. 1959;104(3):360-364.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Chlorpropamide is a new oral antidiabetic agent. Its chemical name is N-propyl-N'-(p-chloro-benzenesulfonyl)urea. The structural formula (Fig. 1) is similar to other sulfonamide derivatives which have been observed to have a blood-sugar-lowering effect.

Schneider et al.,¹ in a thorough pharmacological study of more than two years' duration, found chlorpropamide to be an effective, orally active hypoglycemic agent. In the rhesus monkey, this compound was found to be considerably more potent than tolbutamide and, in addition, the duration of the hypoglycemic effect was more prolonged.

The purpose of the investigation reported here was to confirm the antidiabetic properties of chlorpropamide in the human, to study its therapeutic effectiveness, and to disclose the presence or absence of significant side-effects. In particular we wished to observe the effectiveness of chlorpropamide in those patients who were unresponsive to tolbutamide.

Method of Study

Diabetic patients who were taking insulin, those inadequately controlled with tolbutamide, and an . . . [Full Text PDF of this Article]

Author Affiliations
Cheverly, Md.

From the Medical Department of Prince Georges General Hospital, Cheverly, Md., and the Diabetic Clinic, George Washington University Division, District of Columbia General Hospital, Washington, D. C. Associates in Medicine, George Washington University School of Medicine (Drs. Sugar and Thomas), and Resident in Medicine, Prince Georges General Hospital (Dr. Eugenio).

Footnotes
Submitted for publication Nov. 19, 1958.

The chlorpropamide used in this study was supplied as Diabinese, by Dr. D. G. Iezzoni, of Chas. Pfizer & Company, Inc., Brooklyn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?